ARCHIVES

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

Older Patients Tolerate Chemo, Decline Due To Severe Toxicity

February 28, 2003

Also in this 12-page issue: GM Cancer Research Foundation awards annual prizes to four scientists.

June 4, 2004

Tumor Treating Fields Therapy Increased Three-Year Survival

November 25, 2011

DCE Advisers Okay Cooperative Agreements For Epidemiolgic Of Esophageal Cancers

March 29, 1991

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981

Roche Reports New Avastin Results As FDA Mulls Breast Cancer Indication.

February 15, 2008